Update on herpes zoster vaccination: a family practitioner's guide.Can Fam Physician. 2011 Oct; 57(10):1127-31.CF
To answer frequently asked questions surrounding the use of the new herpes zoster (HZ) vaccine.
SOURCES OF INFORMATION
Published results of clinical trials and other studies, recommendations from the Canadian National Advisory Committee on Immunization, and the US Advisory Committee on Immunization Practices; data were also obtained from the vaccine's Health Canada-approved product monograph.
The HZ vaccine is a safe and effective preventive measure for reducing the overall burden and severity of HZ in older adults. The vaccine appears to be cost-effective when administered to adults aged 60 years and older.